Clinical Trials Logo

Filter by:
NCT ID: NCT04820842 Terminated - Clinical trials for Narcolepsy Type 1 (NT 1)

A Study of TAK-994 in Adults With Narcolepsy

Start date: April 30, 2021
Phase: Phase 2
Study type: Interventional

Adults with narcolepsy who have completed the TAK-994-1501 study will be able to take part in this study. The main aim of this study is to check if participants have side effects from TAK-994. Participants will take one of 3 different TAK-994 dose for 8 weeks. Then, half the participants will continue with their dose of TAK-994 and half will take a placebo. In this study, a placebo will look like a TAK-994 tablet but will not have any medicine in it. Participants will take TAK-994 or placebo for 4 weeks. Participants will visit the clinic for a final check-up 2 weeks after their last dose of TAK-994 or placebo. The study doctors will check for side effects from TAK-994 and placebo throughout the study. Participants will continue to record any narcolepsy symptoms as they did in Part B of the TAK 994-1501 study.

NCT ID: NCT04820491 Terminated - Clinical trials for Shoulder Dislocation

Efficient Anterior Shoulder Ultrasound Reduction Multicenter Prospective Randomized Trial

EASiUR
Start date: March 26, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if using ultrasound to diagnosis and confirm reductions of shoulder dislocations impacts the length of an emergency department visit for this condition.

NCT ID: NCT04818814 Terminated - Chronic Pain Clinical Trials

SCI Pain App Intervention Study

Start date: October 4, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if using an app is a feasible and acceptable treatment for chronic pain in persons with spinal cord injury. Participants will have a 50% chance of being asked to listen to 10 minutes of audio-guided meditations using an app each day for six weeks, and a 50% chance of being asked to listen to 10 minutes of engaging and distracting presentations about topics of interest to the individual (TED Talks) for six weeks. All participants will be asked to complete three online surveys about their emotional and physical health lasting 20-30 minutes (one when the participant first enters the study, one six weeks later, and another six weeks later). Additionally, participants will be asked to complete brief (<5 minute) online surveys once a week during the first six weeks of their participation. Participation in this study is very low risk, and participants may not experience any personal benefit from their participation. Participation in this study is entirely voluntary.

NCT ID: NCT04818580 Terminated - Seroma Clinical Trials

Progressive Tension Sutures in Gender Affirming Mastectomy

Start date: March 25, 2021
Phase: N/A
Study type: Interventional

50 patients seeking gender affirming mastectomy will be treated with different closure techniques in each side of their chest - one side will receive progressive tension sutures between pectoral fascia and the mastectomy flap, and the other side will not. Both sides will have drains in the mastectomy site. Rates of hematoma, seroma, and other complications will be compared between each chest side via standard statistical techniques for hypothesis testing.

NCT ID: NCT04817267 Terminated - Opioid-use Disorder Clinical Trials

Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings

Start date: March 11, 2022
Phase: N/A
Study type: Interventional

This randomized controlled pilot study will evaluate feasibility, acceptability, and potential efficacy of an app, reSET-O, for patients being started on buprenorphine in acute care settings.

NCT ID: NCT04816916 Terminated - Clinical trials for Hepatic Encephalopathy

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

EMMPOWER
Start date: June 29, 2021
Phase: Phase 2
Study type: Interventional

This is a global study to compare the effects of AXA1665, an orally active mixture of amino acids, compared to placebo, on cognitive and physical function, as well as the safety and tolerability of AXA1665.

NCT ID: NCT04815018 Terminated - Clinical trials for SARS-CoV-2 Infection

Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2

COVID-19
Start date: October 7, 2020
Phase:
Study type: Observational

This is a longitudinal, prospective observational study focusing on health-related outcomes relative to potential changes in the respiratory microbiome seen with weekly SARS-CoV-2 testing in nursing home residents.

NCT ID: NCT04814810 Terminated - Hemorrhage Clinical Trials

A 48 Subject Study Using Non-invasive Multi-Technology Measurements for Early Detection of Ongoing Hemorrhage

Start date: February 1, 2021
Phase:
Study type: Observational

Early detection of ongoing hemorrhage (OH) before onset of hemorrhagic shock is a universally acknowledged great unmet need, and particularly important after traumatic injury. Delays in the detection of OH are associated with a "failure to rescue" and a dramatic deterioration in prognosis once the onset of clinically frank shock has occurred. An early alert to the presence of OH would save countless lives. This is a single site study, enrolling 48 patients undergoing liver resection in a "no significant risk" prospective clinical trial to: 1) further identify a minimal subset of noninvasive measurement technologies necessary for the desired diagnostic performance, 2) validate the performance of our Phase I algorithm, and 3) re-train the algorithm to a Phase II human iteration. The main outcome variables are non-invasive measurements that will be used for machine learning, not real-time patient management. The data generated will be used later for discovery and validation in traditional and innovative machine learning.

NCT ID: NCT04814433 Terminated - Clinical trials for Opioid Pain Medication

Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation

Start date: March 24, 2021
Phase: Phase 4
Study type: Interventional

This study is a prospective randomized trial examining the effect of topically combined antifibrinolytics (Tranexamic acid) with local anesthetics in all electively created surgical wound beds in hand surgery to provide long term pain relief and decrease the use of postoperative narcotics.

NCT ID: NCT04812743 Terminated - Cancer of Colon Clinical Trials

Colorectal Health Research Champions

Start date: January 10, 2020
Phase: N/A
Study type: Interventional

The purpose of the Colorectal Health Research Champions program is to provide accurate and reliable colorectal health cancer information that they can share within their communities to encourage cancer prevention, screening, and early detection, as well as the importance of participating in research.